| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 18.370 | 44.330 | 46.352 | 78.475 | 86.457 | 91.422 | 155.632 | 215.356 |
| Total Income - EUR | - | - | 18.370 | 44.972 | 46.746 | 80.046 | 86.571 | 91.822 | 156.532 | 216.105 |
| Total Expenses - EUR | - | - | 11.072 | 38.103 | 42.630 | 65.783 | 46.469 | 101.931 | 116.839 | 149.818 |
| Gross Profit/Loss - EUR | - | - | 7.298 | 6.869 | 4.116 | 14.262 | 40.102 | -10.110 | 39.693 | 66.287 |
| Net Profit/Loss - EUR | - | - | 6.131 | 6.350 | 3.679 | 13.438 | 39.220 | -11.030 | 38.128 | 57.384 |
| Employees | - | - | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Justin Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 149 | 5.643 | 4.799 | 11.781 | 10.096 | 8.496 | 6.844 | 38.480 |
| Current Assets | - | - | 18.534 | 20.364 | 46.215 | 88.077 | 125.281 | 100.235 | 150.613 | 288.881 |
| Inventories | - | - | 0 | 2.240 | 5.116 | 53.669 | 85.593 | 53.595 | 62.357 | 163.514 |
| Receivables | - | - | 18.370 | 16.695 | 37.283 | 33.483 | 35.772 | 41.126 | 81.611 | 124.550 |
| Cash | - | - | 164 | 1.429 | 3.817 | 926 | 3.916 | 5.514 | 6.645 | 817 |
| Shareholders Funds | - | - | 6.131 | 12.411 | 15.849 | 28.987 | 67.564 | 56.744 | 94.700 | 243.333 |
| Social Capital | - | - | 0 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 12.552 | 13.596 | 35.165 | 70.871 | 67.812 | 51.987 | 62.757 | 84.302 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1086 - 1086" | |||||||||
| CAEN Financial Year |
1086
|
|||||||||
Comments - Justin Pharma Srl